logo
Home
Publications
About the Authors
About the Authors
Deutsch
Englisch
Contact
Impressum
Nutzung
Data Protection
Login
logo
Home
Publications
About the Authors
About the Authors
Deutsch
Englisch
Contact
Impressum
Nutzung
Data Protection
Login
Dippel, Franz-Werner
Sanofi-Aventis Deutschland GmbH
Publications:
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.